Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Miguel O’Ryan, Carlo Giaquinto & Bernd Benninghoff. (2015) Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa. Expert Review of Vaccines 14:8, pages 1099-1112.
Read now
Read now
Articles from other publishers (23)
Jumi Yi & Andi L. Shane. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
388
395.e2
.
Mónica Arteaga, Juliana Velasco, Shelly Rodriguez, Maricel Vidal, Carolina Arellano, Francisco Silva, Leandro J. Carreño, Roberto Vidal & David A. Montero. (2020) Genomic characterization of the non-O1/non-O139 Vibrio cholerae strain that caused a gastroenteritis outbreak in Santiago, Chile, 2018. Microbial Genomics 6:3.
Crossref
Crossref
Feodorova, Lyapina, Zaitsev, Khizhnyakova, Sayapina, Ulianova, Ulyanov & Motin. (2019) New Promising Targets for Synthetic Omptin-Based Peptide Vaccine against Gram-Negative Pathogens. Vaccines 7:2, pages 36.
Crossref
Crossref
Sanghita Sarkar, Michael S. Piepenbrink, Madhubanti Basu, Juilee Thakar, Michael C. Keefer, Ann J. Hessell, Nancy L. Haigwood & James J. Kobie. (2019) IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine. Vaccine 37:17, pages 2322-2330.
Crossref
Crossref
Johannes Lind, Lina Schollin Ask, Sol Juarez & Anders Hjern. (2018) Hospital care for viral gastroenteritis in socio-economic and geographical context in Sweden 2006-2013. Acta Paediatrica 107:11, pages 2011-2018.
Crossref
Crossref
Eileena Mohanty, Budheswar Dehury, Ashok Kumar Satapathy & Bhagirathi Dwibedi. (2018) Design and testing of a highly conserved human rotavirus VP8* immunogenic peptide with potential for vaccine development. Journal of Biotechnology 281, pages 48-60.
Crossref
Crossref
Susmita Das, Nirmal K Mohakud, Mrutyunjay Suar & Bikash R Sahu. (2018) Vaccine development for enteric bacterial pathogens: Where do we stand?. Pathogens and Disease 76:5.
Crossref
Crossref
A. Lawan, F.F.A. Jesse, U.H. Idris, M.N. Odhah, M. Arsalan, N.A. Muhammad, K.R. Bhutto, I.D. Peter, G.A. Abraham, A.H. Wahid, M.L. Mohd-Azmi & M. Zamri-Saad. (2018) Mucosal and systemic responses of immunogenic vaccines candidates against enteric Escherichia coli infections in ruminants: A review. Microbial Pathogenesis 117, pages 175-183.
Crossref
Crossref
Camille Webb & Miguel M. Cabada. (2018) A Review on Prevention Interventions to Decrease Diarrheal Diseases’ Burden in Children. Current Tropical Medicine Reports 5:1, pages 31-40.
Crossref
Crossref
Jumi Yi & Andi L. Shane. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
376
383.e2
.
Sabrina L. Slater, Agnes M. Sågfors, Dominic J. Pollard, David Ruano-Gallego & Gad Frankel. 2018. Escherichia coli, a Versatile Pathogen. Escherichia coli, a Versatile Pathogen
51
72
.
Xiao Wang, Da Teng, Qingfeng Guan, Ruoyu Mao, Ya Hao, Xiumin Wang, Junhu Yao & Jianhua Wang. (2017) Escherichia coli outer membrane protein F (OmpF): an immunogenic protein induces cross-reactive antibodies against Escherichia coli and Shigella. AMB Express 7:1.
Crossref
Crossref
Miguel O’Ryan. (2017) Rotavirus Vaccines: a story of success with challenges ahead. F1000Research 6, pages 1517.
Crossref
Crossref
Renata Albuquerque Costa, Oscarina Viana de Sousa, Ernesto Hofer, Jair Mafezoli, Francisco Geraldo Barbosa & Regine Helena Silva dos Fernandes Vieira. (2017)
Thiocarbamates from
Moringa oleifera
Seeds Bioactive against Virulent and Multidrug-Resistant
Vibrio
Species
. BioMed Research International 2017, pages 1-6.
Crossref
Crossref
Marcelle Figueira Marques da Silva, Tulio Machado Fumian, Rosane Maria Santos de Assis, Alexandre Madi Fialho, Filipe Anibal Carvalho-Costa, Juliana da Silva Ribeiro de Andrade & José Paulo Gagliardi Leite. (2017) VP7 and VP8* genetic characterization of group A rotavirus genotype G12P[8]: Emergence and spreading in the Eastern Brazilian coast in 2014. Journal of Medical Virology 89:1, pages 64-70.
Crossref
Crossref
Laurie Boithias, Marc Choisy, Noy Souliyaseng, Marine Jourdren, Fabrice Quet, Yves Buisson, Chanthamousone Thammahacksa, Norbert Silvera, Keooudone Latsachack, Oloth Sengtaheuanghoung, Alain Pierret, Emma Rochelle-Newall, Sylvia Becerra & Olivier Ribolzi. (2016) Hydrological Regime and Water Shortage as Drivers of the Seasonal Incidence of Diarrheal Diseases in a Tropical Montane Environment. PLOS Neglected Tropical Diseases 10:12, pages e0005195.
Crossref
Crossref
H. Peidro-Guzmán, K. Marrero-Domínguez, T. Ledón-Pérez & R. Fando-Calzada. (2016) Desarrollo de un ensayo de PCR para detectar los genes codificadores de la toxina del cólera (ctxAB) en preparaciones del candidato vacunal vivo atenuado CV638. Vacunas 17:2, pages 55-61.
Crossref
Crossref
Elena Moroz, Simon Matoori & Jean-Christophe Leroux. (2016) Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts. Advanced Drug Delivery Reviews 101, pages 108-121.
Crossref
Crossref
Peter J. Hotez, Maria Elena Bottazzi & Ulrich Strych. (2016) New Vaccines for the World's Poorest People. Annual Review of Medicine 67:1, pages 405-417.
Crossref
Crossref
Anthony W. Segal. (2016) Making sense of the cause of Crohn’s – a new look at an old disease. F1000Research 5, pages 2510.
Crossref
Crossref
Mark S. Riddle, Barbara Kowalcyk & Chad K. Porter. 2016. Comprehensive Gut Microbiota. Comprehensive Gut Microbiota
389
399
.
Annick Hens, Valerie Asselman, Ilse De Coster & Pierre Van Damme. (2015) Nieuwe vaccins. Bijblijven 31:7, pages 535-554.
Crossref
Crossref
Stephanie M. Karst & Ralph S. Baric. (2015) What Is the Reservoir of Emergent Human Norovirus Strains?. Journal of Virology 89:11, pages 5756-5759.
Crossref
Crossref